GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis
Article courtesy of GSK GSK today announced positive headline results for intravenous (IV) Benlysta (belimumab) in the largest controlled phase 3 study in active lupus nephritis (LN), an [...]